TherapeuticsMD
TXMD
TXMD
143 hedge funds and large institutions have $791M invested in TherapeuticsMD in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
52
Reduced
32
Closed
24
Calls
$1.92M
Puts
$3.19M
Net Calls
-$1.27M
Net Calls Change
+$3.29M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$16.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10.1M |
| 3 |
Axa
Paris,
France
|
+$5.17M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.9M |
| 5 |
Renaissance Technologies
New York
|
+$892K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.3M |
| 2 |
NM
Newtyn Management
New York
|
-$7.55M |
| 3 |
NC
Nexthera Capital
New York
|
-$3.19M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.9M |
| 5 |
BlackRock
New York
|
-$2.47M |
